Vitamin D exhibits beneficial immunomodulatory effects in patients with multiple sclerosis
A double-blind, single-center randomized pilot study carried out at Johns Hopkins University (MD, USA) has demonstrated that high-dose vitamin D3 (cholecalciferol) supplementation can result in a reduction in inflammatory T cells that are associated with disease severity in multiple sclerosis (MS). The findings were published recently in the journal Neurology. In MS, there is a correlation between low levels of vitamin D and greater disability and disease activity. Low levels of vitamin D in the blood are also linked to a higher risk of developing the condition. The current study examined the safety and immunologic effects of cholecalciferol administration for...